The childhood immunization schedule and safety: Stakeholder concerns, scientific evidence, and future studies

The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies

Volumn , Issue , 2013, Pages 1-219

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85024094049     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.17226/13563     Document Type: Book

References (272)

1. CDC (Centers for Disease Control and Prevention). 2011a. General recommendations on immunization-recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and Reports: Morbidity and Mortality Weekly Report 60(2):1-64.
2. CDC. 2011b. Immunization Safety Office scientific agenda. Atlanta, GA: Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention.
3. CDC. 2012a. Final 2011 reports of nationally notifiable diseases. Morbidity and Mortality Weekly Report 61(32):624-637.
4. CDC. 2012b. Vaccination coverage among children in kindergarten-United States, 2011-12 school year. Morbidity and Mortality Weekly Report 61(33):647-652.
5. Dempsey, A.F., S. Schaffer, D. Singer, A. Butchart, M. Davis, and G.L. Freed. 2011. Alternative vaccination schedule preferences among parents of young children. Pediatrics 128(5):848-856.
6. Felkin, D.R., D.C. Lezotte, R.F. Hamman, D.A. Salmon, R.T. Chen, and R.E. Hoffman. 2000. Individual and community risks of measles and pertussis associated with personal exemptions to immunization. Journal of the American Medical Association 284(24): 3145-3150.
7. Fineberg, H.V. 2011. A perspective on vaccines: President's address. Paper presented at Institute of Medicine Annual Meeting, Washington, DC.
8. Gregson, A.L., and R. Edelman. 2003. Does antigenic overload exist? The role of multiple immunizations in infants Immunology and Allergy. Clinics of North America 23(4):649-664.
9. IOM (Institute of Medicine). 2002. Immunization safety review: Multiple immunizations and immune dysfunction. Washington, DC: National Academy Press.
10. IOM. 2012. Adverse effects of vaccines. Washington, DC: The National Academies Press.
11. Lopalco, P.L., H.G. de Carvalho, P. Kreidl, K. Leitmeyer, and J. Giesecke. 2009. Childhood vaccination schedules in Europe vary widely. Is this a problem? Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 52(11):1095-1098.
12. NVAC (National Vaccine Advisory Committee). 2009. Recommendations on the Centers for Disease Control and Prevention Immunization Safety Office draft 5-year scientific agenda. Washington, DC: National Vaccine Advisory Committee.
13. Offit, P.A., J. Quarles, M.A. Gerber, C.J. Hackett, E.K. Marcuse, T.R. Kollman, B.G. Gellin, and S. Landry. 2002. Addressing parents' concerns: Do multiple vaccines overwhelm or weaken the infant's immune system? Pediatrics 109(1):124-129.
14. Omer, S.B., W.K. Pan, N.A. Halsey, S. Stokley, L.H. Moulton, A.M. Navar, M. Pierce, and D.A. Salmon. 2006. Nonmedical exemptions to school immunization requirements: Secular trends and association of state policies with pertussis incidence. Journal of the American Medical Association 296(14):1757-1763.
15. Roush, S.W., T.V. Murphy, and Vaccine-Preventable Disease Table Working Group. 2007. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. Journal of the American Medical Association 298(18):2155-2163.
16. Stern, A.M., and H. Markel. 2005. The history of vaccines and immunization: Familiar patterns, new challenges. Health Affairs 24(3):611-621.
17. WHO (World Health Organization). 2012. Immunization, vaccines and biologicals. Geneva, Switzerland: World Health Organization. http://www.who.int/immunization/policy/immunization_tables/en/index. html (accessed September 2012).
18. Anderson, R.M., and R.M. May. 1982. Directly transmitted infectious diseases: Control by vaccination. Science 215(4536):1053-1060.
19. Anderson, R.M., and R.M. May. 1992. Infectious Diseases of Humans: Dynamics and Control, New York: Oxford University Press.
20. Baylor, N.W., and K. Midthun. 2004. Regulation and testing of vaccines. In Vaccines, edited by S.A. Plotkin and W.A. Orenstein. Philadelphia, PA: Saunders Elsevier. Pp. 1611-1627.
21. Becker, N.G. 1989. Analysis of infectious disease data, vol. 33. Boca Raton, FL: Chapman & Hall/CRC.
22. Bedognetti, D., G. Zoppoli, C. Massucco, E. Zanardi, S. Zupo, A. Bruzzone, M.R. Sertoli, E. Balleari, O. Racchi, and M. Messina. 2011. Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens. Journal of Immunology 186(10):6044-6055.
23. CDC (Centers for Disease Control and Prevention). 2010. The school entry immunization assessment report, 2004-05. Atlanta, GA: National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention.
24. CDC. 2011a. General recommendations on immunization-recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and Reports 60(2):1-64.
25. CDC. 2011b. Guide to vaccine contraindications and precautions. Atlanta, GA: Centers for Disease Control and Prevention. http://www.cdc.gov/vaccines/recs/vacadmin/contra indications.htm (accessed July 9, 2012).
26. CDC. 2011c. National and state vaccination coverage among children aged 19-35 months-United States, 2010. Morbidity and Mortality Weekly Reports 60(34):1157-1163.
27. CDC. 2011d. Vaccination coverage among children in kindergarten-United States, 2009-10 school year. Morbidity and Mortality Weekly Reports 60(21):700-704.
28. CDC. 2012a. National, state, and local area vaccination coverage among children aged 19-35 months-United States, 2011. Morbidity and Mortality Weekly Reports 61(35):689-696.
29. CDC. 2012b. New framework (GRADE) for development of evidence-based recommendations by the Advisory Committee on Immunization Practices. Morbidity and Mortality Weekly Reports 61(18):327.
30. CDC. 2012c. Past immunization schedules. Atlanta, GA: Centers for Disease Control and Prevention. http://www.cdc.gov/vaccines/schedules/past.html (accessed June 12, 2012).
31. CDC. 2012d. Principles of vaccination. In Epidemiology and prevention of vaccine-preventable diseases. Atlanta, GA: Centers for Disease Control and Prevention.
32. Chen, R.T., and W.A. Orenstein. 1996. Epidemiologic methods in immunization programs. Epidemiologic Reviews 18(2):99-117.
33. Chen, R.T., R.L. Davis, and P.H. Rhodes. 2005. Special methodological issues in pharmacoepidemiology studies of vaccine safety. In Pharmacoepidemiology, Fourth Edition, edited by B.L. Strom. West Sussex, England: John Wiley & Sons Ltd. Pp. 455-485.
34. Cook, K.M., and G. Evans. 2011. The National Vaccine Injury Compensation Program. Pediatrics 127(Suppl 1):S74-S77.
35. Farizo, K. 2012. Assessing the safety of vaccines at the FDA: Pre-and post-licensure evaluation. Presentation to Meeting 2 of the Institute of Medicine Committee on the Assessment of Studies of Health Outcomes Related to the Recommended Childhood Immunization Schedule, Seattle, WA, March 8.
36. FDA (Food and Drug Administration). 2010. Biologics License Applications (BLA) process (CBER). Rockville, MD: Food and Drug Administration. http://www.fda.gov/Biologics Blood Vaccines/DevelopmentApprovalProcess/BiologicsLicenseApplicationsBLAProcess/default.htm (accessed November 2, 2012).
37. Fine, P.E. 1993. Herd immunity: History, theory, practice. Epidemiologic Reviews 15(2): 265-302.
38. Fine, P., K. Eames, and D.L. Heymann. 2011. "Herd immunity": A rough guide. Clinical Infectious Diseases 52(7):911-916.
39. HHS (U.S. Department of Health and Human Services). 2012. National Vaccine Advisory Committee. Washington, DC: U.S. Department of Health and Human Services. http://www.hhs.gov/nvpo/nvac/index.html (accessed July 30, 2012).
40. Hudgens, M.G., P.B. Gilbert, and S.G. Self. 2004. Endpoints in vaccine trials. Statistical Methods in Medical Research 13(2):89-114.
41. IOM (Institute of Medicine). 2012. Adverse effects of vaccines: Evidence and causality. Washington, DC: The National Academies Press.
42. Keeling, M.J., and P. Rohani. 2008. Modeling Infectious Diseases: Of Humans and Animals. Princeton, NJ: Princeton University Press.
43. Kroger, A.T., C.V. Sumaya, L.K. Pickering, and W.L. Atkinson. 2011. General recommendations on immunization-recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and Reports 60(2):1-64.
44. Liang, X.F., H.Q. Wang, J.Z. Wang, H.H. Fang, J. Wu, F.C. Zhu, R.C. Li, S.L. Xia, Y.L. Zhao, F.J. Li, S.H. Yan, W.D. Yin, K. An, D.J. Feng, X.L. Cui, F.C. Qi, C.J. Ju, Y.H. Zhang, Z.J. Guo, P.Y. Chen, Z. Chen, K.M. Yan, and Y. Wang. 2010. Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: A multicentre, double-blind, randomised, placebo-controlled trial. Lancet 375(9708):56-66.
45. Luman, E.T., L.E. Barker, K.M. Shaw, M.M. McCauley, J.W. Buehler, and L.K. Pickering. 2005. Timeliness of childhood vaccinations in the United States: Days undervaccinated and number of vaccines delayed. Journal of the American Medical Association 293(10):1204-1211.
46. Melvold, R.W. 2009. The immune system: Biologic and clinical aspects. In Patterson's allergic diseases, vol. 7, edited by L. C. Grammer and P. A. Greenberger. Philadelphia, PA: Walters Kluwer/Lippincott Williams & Wilkins. Pp. 1-21.
47. NVAC (National Vaccine Advisory Committee). 2011. National Vaccine Advisory Committee draft white paper on the United States vaccine safety system. National Vaccine Advisory Committee, Washington, DC.
48. Omer, S.B., W.K. Pan, N.A. Halsey, S. Stokley, L.H. Moulton, A.M. Navar, M. Pierce, and D.A. Salmon. 2006. Nonmedical exemptions to school immunization requirements: Secular trends and association of state policies with pertussis incidence. Journal of the American Medical Association 296(14):1757-1763.
49. Opel, D.J., R. Mangione-Smith, J.A. Taylor, C. Korfiatis, C. Wiese, S. Catz, and D.P. Martin. 2011. Development of a survey to identify vaccine-hesitant parents: The parent attitudes about childhood vaccines survey. Human Vaccines 7(4):419-425.
50. Siegrist, C.A. 2008. Vaccine immunology. In Vaccines, vol. 5, edited by S.A. Plotkin, W.A. Orenstein, and P.A. Offit. Philadelphia, PA: Saunders Elsevier.
51. Smith, J.C. 2010. The structure, role, and procedures of the US Advisory Committee on Immunization Practices (ACIP). Vaccine 28:A68-A75.
52. Smith, J.C., D.E. Snider, L.K. Pickering, and Advisory Committee on Immunization Practices. 2009. Immunization policy development in the United States: The role of the Advisory Committee on Immunization Practices. Annals of Internal Medicine 150(1):45-49.
53. AHRQ (Agency for Healthcare Research and Quality). 2009. Overview of HCUP. Rockville, MD: Agency for Healthcare Research and Quality. http://www.hcup-us.ahrq.gov/overview.jsp (accessed September 19, 2012).
54. Andrews, N., J. Stowe, E. Miller, and B. Taylor. 2007. Post-licensure safety of the meningococcal group C conjugate vaccine. Human Vaccines 3(2):59-63.
55. Baggs, J., J. Gee, E. Lewis, G. Fowler, P. Benson, T. Lieu, A. Naleway, N.P. Klein, R. Baxter, E. Belongia, J. Glanz, S.J. Hambidge, S.J. Jacobsen, L. Jackson, J. Nordin, and E. Weintraub. 2011. The Vaccine Safety Datalink: A model for monitoring immunization safety. Pediatrics 127(Suppl 1):S45-S53.
56. Barlow, W.E., R.L. Davis, J.W. Glasser, P.H. Rhodes, R.S. Thompson, J.P. Mullooly, S.B. Black, H.R. Shinefield, J.I. Ward, S.M. Marcy, F. DeStefano, R.T. Chen, V. Immanuel, J.A. Pearson, C.M. Vadheim, V. Rebolledo, D. Christakis, P.J. Benson, N. Lewis, and Centers for Disease Control and Prevention Vaccine Safety Datalink Working Group. 2001. The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. New England Journal of Medicine 345(9):656-661.
57. Brighton Collaboration. 2012. Brighton Collaboration. Brighton, United Kingdom: Brighton Collaboration. https://brightoncollaboration.org/public.html (accessed August 5, 2012).
58. CDC (Centers for Disease Control and Prevention). 2011a. National Immunization Survey. Atlanta, GA: Centers for Disease Control and Prevention. http://www.cdc.gov/nchs/nis.htm (accessed June 15, 2012).
59. CDC. 2011b. Vaccine Safety Datalink (VSD) project. Atlanta, GA: Centers for Disease Control and Prevention. http://www.cdc.gov/vaccinesafety/Activities/VSD.html (accessed June 12, 2012).
60. CDC. 2011c. Clinical Immunization Safety Assessment (CISA) network. Atlanta, GA: Centers for Disease Control and Prevention. http://www.cdc.gov/vaccinesafety/Activities/cisa.html (accessed November 28, 2012).
61. CDC. 2012a. 2010 IISAR data participation rates. Atlanta, GA: Centers for Disease Control and Prevention. http://www.cdc.gov/vaccines/programs/iis/annual-report-IISAR/2010-data.html#child (accessed September 3, 2012).
62. CDC. 2012b. Meaningful use. Atlanta, GA: Centers for Disease Control and Prevention. http://www.cdc.gov/ehrmeaningfuluse (accessed October 3, 2012).
63. CDC. 2012c. Progress in immunization information systems-United States, 2010. MMWR Morbidity and Mortality Weekly Reports 61(25):464-467.
64. CDC and FDA (Food and Drug Administration). 2012. Vaccine Adverse Event Reporting System. Atlanta, GA: Centers for Disease Control and Prevention; Rockville, MD: Food and Drug Administration. http://vaers.hhs.gov/index (accessed June 1, 2012).
65. Chen, R.T., J.W. Glasser, P.H. Rhodes, R.L. Davis, W.E. Barlow, R.S. Thompson, J.P. Mullooly, S.B. Black, H.R. Shinefield, and C.M. Vadheim. 1997. Vaccine Safety Datalink project: A new tool for improving vaccine safety monitoring in the United States. Pediatrics 99(6):765-773.
66. Chen, R., F. DeStefano, R. Davis, L. Jackson, R. Thompson, J. Mullooly, S. Black, H. Shinefield, C. Vadheim, and J. Ward. 2000. The Vaccine Safety Datalink: Immunization research in health maintenance organizations in the USA. Bulletin of the World Health Organization 78(2):186-194.
67. Cortese, M.M., J. LeBlanc, K.E. White, R.C. Jerris, P. Stinchfield, K.L. Preston, J. Meek, L. Odofin, S. Khizer, C.A. Miller, V. Buttery, S. Mijatovic-Rustempasic, J. Lewis, U.D. Parashar, and L.C. Immergluck. 2011. Leveraging state immunization information systems to measure the effectiveness of rotavirus vaccine. Pediatrics 128(6):E1474-E1481.
68. CPRD (Clincal Practice Research Datalink). 2012. Clinical Practice Research Datalink (CPRD). London, United Kingdom: Medicines and Healthcare Products Regulatory Agency, National Institute for Health Research. http://www.cprd.com/intro.asp (accessed July 2, 2012).
69. Curlin, G., S. Landry, J. Bernstein, R.L. Gorman, B. Mulach, C.J. Hackett, S. Foster, S.E. Miers, and P. Strickler-Dinglasan. 2011. Integrating safety and efficacy evaluation throughout vaccine research and development. Pediatrics 127(Suppl 1):S9-S15.
70. Curns, A.T., F. Coffin, J.W. Glasser, R.I. Glass, and U.D. Parashar. 2009. Projected impact of the new rotavirus vaccination program on hospitalizations for gastroenteritis and rotavirus disease among US children <5 years of age during 2006-2015. Journal of Infectious Diseases 200(Suppl 1):S49-S56.
71. Curns, A.T., C.A. Steiner, M. Barrett, K. Hunter, E. Wilson, and U.D. Parashar. 2010. Reduction in acute gastroenteritis hospitalizations among US children after introduction of rotavirus vaccine: Analysis of hospital discharge data from 18 US states. Journal of Infectious Diseases 201(11):1617-1624.
72. DeStefano, F. 2001. The Vaccine Safety Datalink project. Pharmacoepidemiology and Drug Safety 10(5):403-406.
73. Dieleman, J., S. Romio, K. Johansen, D. Weibel, J. Bonhoeffer, and M. Sturkenboom. 2011. Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: Multinational case-control study in Europe. BMJ 343:d3908.
74. Fischer, T.K., C. Viboud, U. Parashar, M. Malek, C. Steiner, R. Glass, and L. Simonsen. 2007. Hospitalizations and deaths from diarrhea and rotavirus among children <5 years of age in the United States, 1993-2003. Journal of Infectious Diseases 195(8):1117-1125.
75. Grijalva, C.G., K.A. Poehling, J.P. Nuorti, Y. Zhu, S.W. Martin, K.M. Edwards, and M.R. Griffin. 2006. National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States. Pediatrics 118(3):865-873.
76. Grijalva, C.G., J.P. Nuorti, P.G. Arbogast, S.W. Martin, K.M. Edwards, and M.R. Griffin. 2007. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: A time-series analysis. Lancet 369(9568):1179-1186.
77. Grijalva, C.G., Y. Zhu, L. Simonsen, and M.R. Griffin. 2010a. Establishing the baseline burden of influenza in preparation for the evaluation of a countywide school-based influenza vaccination campaign. Vaccine 29(1):123-129.
78. Grijalva, C.G., Y. Zhu, L. Simonsen, E. Mitchel, and M.R. Griffin. 2010b. The population impact of a large school-based influenza vaccination campaign. PLoS One 5(11):e15097.
79. Guh, A.Y., and J.L. Hadler. 2011. Use of the state immunization information system to assess rotavirus vaccine effectiveness in Connecticut, 2006-2008. Vaccine 29(37):6155-6158.
80. Hackett, C. 2012. Phenotyping of Human Immune Responses in Vaccination. Presentation to Meeting 1 of the Institute of Medicine Committee on the Assessment of Studies of Health Outcomes Related to the Recommended Childhood Immunization Schedule, Washington, DC, February 9.
81. Hedden, E.M., A.B. Jessop, and R.I. Field. 2012. Childhood immunization reporting laws in the United States: Current status. Vaccine 30(49):7059-7066.
82. HIPC (Human Immunology Project Consortium). 2012. The Human Immunology Project Consortium. Rockville, MD: Human Immunology Project Consortium, Division of Allergy, Immunology, and Transplantation, National Institute of Allergy and Infectious Diseases. http://www.immuneprofiling.org/hipc/page/show (accessed October 1, 2012).
83. Hviid, A., M. Stellfeld, J. Wohlfahrt, and M. Melbye. 2003. Association between thimerosalcontaining vaccine and autism. Journal of the American Medical Association 290(13): 1763-1766.
84. Hviid, A., M. Stellfeld, J. Wohlfart, and M. Melbye. 2004. Childhood vaccination and type 1 diabetes. New England Journal of Medicine 350(14):1398-1404.
85. Luman, E.T., L.E. Barker, K.M. Shaw, M.M. McCauley, J.W. Buehler, and L.K. Pickering. 2005. Timeliness of childhood vaccinations in the United States: Days undervaccinated and number of vaccines delayed. Journal of the American Medical Association 293(10):1204-1211.
86. Ma, L., A.C. El Khoury, and R.F. Itzler. 2009. The burden of rotavirus hospitalizations among Medicaid and non-Medicaid children younger than 5 years old. American Journal of Public Health 99(Suppl 2):S398-S404.
87. Macdonald, N., and R. Bortolussi. 2011. A harmonized immunization schedule for Canada: A call to action. Paediatrics and Child Health 16(1):29-31.
88. Madsen, K.M., A. Hviid, M. Vestergaard, D. Schendel, J. Wohlfahrt, P. Thorsen, J. Olsen, and M. Melbye. 2002. A population-based study of measles, mumps, and rubella vaccination and autism. Ugeskrift for Laeger 164(49):5741-5744.
89. McCavit, T.L., L. Xuan, S. Zhang, G. Flores, and C.T. Quinn. 2012. Hospitalization for invasive pneumococcal disease in a national sample of children with sickle cell disease before and after PCV7 licensure. Pediatric Blood and Cancer 58(6):945-949.
90. Miller, E. 2012. Vaccine policy and safety surveillance in England and Wales. Presentation to Meeting 3 of the Institute of Medicine Committee on the Assessment of Studies of Health Outcomes Related to the Recommended Childhood Immunization Schedule, Washington, DC, May 29.
91. Miller, E., P. Waight, C.P. Farrington, N. Andrews, J. Stowe, and B. Taylor. 2001. Idiopathic thrombocytopenic purpura and MMR vaccine. Archives of Disease in Childhood 84(3):227-229.
92. Mini-Sentinel Coordinating Center. 2011. Mini-Sentinel distributed database "at a glance." Silver Spring, MD: Food and Drug Administration, Sentinel Initiative. http://mini-sentinel.org/about_us/MSDD_At-a-Glance.aspx (accessed November 12, 2012).
93. Nguyen, M., R. Ball, K. Midthun, and T.A. Lieu. 2012. The Food and Drug Administration's Post-licensure Rapid Immunization Safety Monitoring program: Strengthening the federal vaccine safety enterprise. Pharmacoepidemiol Drug Safety 21(Suppl 1):S291-S297.
94. NVAC (National Vaccine Advisory Committee). 2011. National Vaccine Advisory Committee draft white paper on the United States vaccine safety system. Unpublished. National Vaccine Advisory Committee, Washington, DC.
95. Pedersen, C.B., H. Gøtzsche, J.Ø. Møller, and P.B. Mortensen. 2006. The Danish Civil Registration System. Danish Medical Bulletin 53(4):441-449.
96. Poehling, K.A., P.G. Szilagyi, K. Edwards, E. Mitchel, R. Barth, H. Hughes, B. Lafleur, S.J. Schaffer, B. Schwartz, and M.R. Griffin. 2003. Streptococcus pneumoniae-related illnesses in young children: Secular trends and regional variation. Pediatric Infectious Disease Journal 22(5):413-418.
97. Poehling, K.A., P.G. Szilagyi, C.G. Grijalva, S.W. Martin, B. LaFleur, E. Mitchel, R.D. Barth, J.P. Nuorti, and M.R. Griffin. 2007. Reduction of frequent otitis media and pressureequalizing tube insertions in children after introduction of pneumococcal conjugate vaccine. Pediatrics 119(4):707-715.
98. Public Health Agency of Canada. 2006. Canadian immunization guide. Ottawa, Ontario, Canada: Public Health Agency of Canada.
99. Scheifele, D.W., S.A. Halperin, and CPS/Health Canada, Immunization Monitoring Program, Active (IMPACT). 2003. Immunization Monitoring Program, Active: A model of active surveillance of vaccine safety. Seminars in Pediatric Infectious Diseases 14(3):213-219.
100. Simonsen, L., D. Morens, A. Elixhauser, M. Gerber, M. Van Raden, and W. Blackwelder. 2001. Effect of rotavirus vaccination programme on trends in admission of infants to hospital for intussusception. Lancet 358(9289):1224-1229.
101. Simonsen, L., R.J. Taylor, Y. Young-Xu, M. Haber, L. May, and K.P. Klugman. 2011. Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States. mBio 2(1):1-10.
102. Statens Serum Institut. 2012. Statens Serum Institut. Copenhagen, Denmark: Statens Serum Institut. http://www.ssi.dk/English.aspx (accessed July 10, 2012).
103. Tate, J.E., L. Simonsen, C. Viboud, C. Steiner, M.M. Patel, A.T. Curns, and U.D. Parashar. 2008. Trends in intussusception hospitalizations among US infants, 1993-2004: Implications for monitoring the safety of the new rotavirus vaccination program. Pediatrics 121(5):e1125-e1132.
104. Thompson, W.W., C. Price, B. Goodson, D.K. Shay, P. Benson, V.L. Hinrichsen, E. Lewis, E. Eriksen, P. Ray, and S.M. Marcy. 2007. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. New England Journal of Medicine 357(13):1281-1292.
105. Thygesen, L.C., C. Daasnes, I. Thaulow, and H. Brønnum-Hansen. 2011. Introduction to Danish (nationwide) registers on health and social issues: Structure, access, legislation, and archiving. Scandinavian Journal of Public Health 39(Suppl 7):S12-S16.
106. Tsai, C.J., M.R. Griffin, J.P. Nuorti, and C.G. Grijalva. 2008. Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States. Clinical Infectious Diseases 46(11):1664-1672.
107. VAESCO (Vaccine Adverse Event Surveillance and Communication). 2010. Vaccine Adverse Event Surveillance and Communication (VAESCO). Stockholm, Sweden: Vaccine Adverse Event Surveillance and Communication. http://vaesco.net/vaesco.html (accessed August 5, 2012).
108. Verstraeten, T., R.L. Davis, F. DeStefano, T.A. Lieu, P.H. Rhodes, S.B. Black, H. Shinefield, R.T. Chen, and Vaccine Safety Datalink Team. 2003. Safety of thimerosal-containing vaccines: A two-phased study of computerized health maintenance organization databases. Pediatrics 112(5):1039-1048.
109. Williams, S.E., B.A. Pahud, C. Vellozzi, P.D. Donofrio, C.L. Dekker, N. Halsey, N.P. Klein, R.P. Baxter, C.D. Marchant, P.S. Larussa, E.D. Barnett, J.I. Tokars, B.E. McGeeney, R.C. Sparks, L.L. Aukes, K. Jakob, S. Coronel, J.J. Sejvar, B.A. Slade, and K.M. Edwards. 2011. Causality assessment of serious neurologic adverse events following 2009 H1N1 vaccination. Vaccine 29(46):8302-8308.
110. Yen, C., J.E. Tate, J.D. Wenk, J.M. Harris II, and U.D. Parashar. 2011. Diarrhea-associated hospitalizations among US children over 2 rotavirus seasons after vaccine introduction. Pediatrics 127(1):e9-e15.
111. Yu, O., K. Bohlke, C.A. Hanson, K. Delaney, T.G. Rees, A. Zavitkovsky, P. Ray, J. Mullooly, S.B. Black, and P. Benson. 2007. Hepatitis B vaccine and risk of autoimmune thyroid disease: A Vaccine Safety Datalink study. Pharmacoepidemiology and Drug Safety 16(7):736-745.
112. Brown, K.F., S.J. Long, M. Ramsay, M.J. Hudson, J. Green, C.A. Vincent, J.S. Kroll, G. Fraser, and N. Sevdalis. 2012. U.K. parents' decision-making about measles-mumps-rubella (MMR) vaccine 10 years after the MMR-autism controversy: A qualitative analysis. Vaccine 30(10):1855-1864.
113. CDC (Centers for Disease Control and Prevention). 2012. National, state, and local area vaccination coverage among children aged 19-35 months-United States, 2011. MMWR Morbidity and Mortality Weekly Reports 61(35):689-696.
114. Chen, R.T., R.L. Davis, and P.H. Rhodes. 2005. Special methodological issues in pharmacoepidemiology studies of vaccine safety. In Pharmacoepidemiology, vol. 4, edited by B.L. Strom. West Sussex, England: John Wiley & Sons, Ltd. Pp. 455-485.
115. Dempsey, A.F., S. Schaffer, D. Singer, A. Butchart, M. Davis, and G.L. Freed. 2011. Alternative vaccination schedule preferences among parents of young children. Pediatrics 128(5):848-856.
116. Diekema, D.S. 2012. Issues leading to vaccine hesitancy. Presentation to Meeting 2 of the Institute of Medicine Committee on the Assessment of Studies of Health Outcomes Related to the Recommended Childhood Immunization Schedule, Seattle, WA, March 8.
117. Diekema, D.S., and the AAP Committee on Bioethics. 2005. Responding to parental refusals of immunization of children. Pediatrics 115(5):1428-1431.
118. Flanagan-Klygis, E.A., L. Sharp, and J.E. Frader. 2005. Dismissing the family who refuses vaccines: A study of pediatrician attitudes. Archives of Pediatrics and Adolescent Medicine 159(10):929-934.
119. Freed, G.L., A.E. Cowan, and S.J. Clark. 2009. Primary care physician perspectives on reimbursement for childhood immunizations. Pediatrics 124(Suppl 5):S466-S471.
120. Freed, G.L., S.J. Clark, A.T. Butchart, D.C. Singer, and M.M. Davis. 2010. Parental vaccine safety concerns in 2009. Pediatrics 125(4):654-659.
121. Freed, G.L., S.J. Clark, A.T. Butchart, D.C. Singer, and M.M. Davis. 2011. Sources and perceived credibility of vaccine-safety information for parents. Pediatrics 127:S107-S112.
122. Gellin, B.G., E.W. Maibach, and E.K. Marcuse. 2000. Do parents understand immunizations? A national telephone survey. Pediatrics 106(5):1097-1102.
123. Gust, D.A., T.W. Strine, E. Maurice, P. Smith, H. Yusuf, M. Wilkinson, M. Battaglia, R. Wright, and B. Schwartz. 2004. Underimmunization among children: Effects of vaccine safety concerns on immunization status. Pediatrics 114(1):e16-e22.
124. Gust, D.A., A. Kennedy, I. Shui, P.J. Smith, G. Nowak, and L.K. Pickering. 2005. Parent attitudes toward immunizations and healthcare providers: The role of information. American Journal of Preventive Medicine 29(2):105-112.
125. Gust, D.A., S. Campbell, A. Kennedy, I. Shui, L. Barker, and B. Schwartz. 2006. Parental concerns and medical-seeking behavior after immunization. American Journal of Preventive Medicine 31(1):32-35.
126. Gust, D.A., N. Darling, A. Kennedy, and B. Schwartz. 2008a. Parents with doubts about vaccines: Which vaccines and reasons why. Pediatrics 122(4):718-725.
127. Gust, D.A., D. Weber, E. Weintraub, A. Kennedy, F. Soud, and A. Burns. 2008b. Physicians who do and do not recommend children get all vaccinations. Journal of Health Communication 13(6):573-582.
128. HIPC (Human Immunology Project Consortium). 2012. The Human Immunology Project Consortium. Rockville, MD: Human Immunology Project Consortium, Division of Allergy, Immunology, and Transplantation, National Institute of Allergy and Infectious Diseases. http://www.immuneprofiling.org/hipc/page/show (accessed October 1, 2012).
129. IOM (Institute of Medicine). 1992. Adverse effects of pertussis and rubella vaccines. Washington, DC: National Academy Press.
130. IOM. 2002. Immunization safety review: Multiple immunizations and immune dysfunction. Washington, DC: National Academy Press.
131. IOM. 2008. Initial guidance for an update of the National Vaccine Plan: A letter report to the National Vaccine Program Office. Washington, DC: The National Academies Press.
132. IOM. 2010. Priorities for the National Vaccine Plan. Washington, DC: The National Academies Press.
133. IOM. 2012. Adverse effects of vaccines: Evidence and causality. Washington, DC: The National Academies Press.
134. Kennedy, A., M. Basket, and K. Sheedy. 2011a. Vaccine attitudes, concerns, and information sources reported by parents of young children: Results from the 2009 HealthStyles survey. Pediatrics 127(Suppl 1):S92-S99.
135. Kennedy, A., K. LaVail, G. Nowak, M. Basket, and S. Landry. 2011b. Confidence about vaccines in the United States: Understanding parents' perceptions. Health Affairs 30(6): 1151-1159.
136. Larson, H.J., L.Z. Cooper, J. Eskola, S.L. Katz, and S. Ratzan. 2011. Addressing the vaccine confidence gap. Lancet 378(9790):526-535.
137. Leib, S., P. Liberatos, and K. Edwards. 2011. Pediatricians' experience with and response to parental vaccine safety concerns and vaccine refusals: A survey of Connecticut pediatricians. Public Health Reports 126(Suppl 2):S13-S23.
138. Levi, B.H. 2007. Addressing parents' concerns about childhood immunizations: A tutorial for primary care providers. Pediatrics 120(1):18-26.
139. Madsen, K.M., and M. Vestergard. 2004. MMR vaccination and autism. Drug Safety 27(12): 831-840.
140. Niederhauser, V.P., G. Baruffi, and R. Heck. 2001. Parental decision-making for the varicella vaccine. Journal of Pediatric Health Care 15(5):236-243.
141. Noble, G.R., R.H. Bernier, E.C. Esber, M.C. Hardegree, A.R. Hinman, D. Klein, and A.J. Saah. 1987. Acellular and whole-cell pertussis vaccines in Japan. Journal of the American Medical Association 257(10):1351-1356.
142. Robison, S.G., H. Groom, and C. Young. 2012. Frequency of alternative immunization schedule use in a metropolitan area. Pediatrics 130(1):32-38.
143. Salmon, D.A., L.H. Moulton, and N.A. Halsey. 2004. Enhancing public confidence in vaccines through independent oversight of postlicensure vaccine safety. American Journal of Public Health 94(6):947-950.
144. Serpell, L., and J. Green. 2006. Parental decision-making in childhood vaccination. Vaccine 24(19):4041-4046.
145. Smith, P.J., S.G. Humiston, E.K. Marcuse, Z. Zhao, C.G. Dorell, C. Howes, and B. Hibbs. 2011. Parental delay or refusal of vaccine doses, childhood vaccination coverage at 24 months of age, and the health belief model. Public Health Reports 126(Suppl 2): S135-S146.
146. Taylor, B., E. Miller, C.P. Farrington, M.C. Petropoulos, I. Favot-Mayaud, J. Li, and P.A. Waight. 1999. Autism and measles, mumps, and rubella vaccine: No epidemiological evidence for a causal association. Lancet 353(9169):2026-2029.
147. Wightman, A., D.J. Opel, E.K. Marcuse, and J.A. Taylor. 2011. Washington State pediatricians' attitudes toward alternative childhood immunization schedules. Pediatrics 128(6):1094-1099.
148. Andrews, N., E. Miller, A. Grant, J. Stowe, V. Osborne, and B. Taylor. 2004. Thimerosal exposure in infants and developmental disorders: A retrospective cohort study in the United Kingdom does not support a causal association. Pediatrics 114(3):584-591.
149. Benke, G., M. Abramson, J. Raven, F.C.K. Thien, and E.H. Walters. 2004. Asthma and vaccination history in a young adult cohort. Australian and New Zealand Journal of Public Health 28(4):336-338.
150. Bremner, S.A., I.M. Carey, S. DeWilde, N. Richards, W.C. Maier, S.R. Hilton, D.P. Strachan, and D.G. Cook. 2005. Timing of routine immunisations and subsequent hay fever risk. Archives of Diseases in Childhood 90(6):567-573.
151. CDC (Centers for Disease Control and Prevention). 2012. Influenza vaccine 2012-inactivated. Atlanta, GA: Centers for Disease Control and Prevention. http://www.cdc.gov/vaccines/pubs/vis/downloads/ vis-flu.pdf (accessed December 6, 2012).
152. David, S., P.E. Vermeer-de Bondt, and N.A.T. van der Maas. 2008. Reactogenicity of infant whole cell pertussis combination vaccine compared with acellular pertussis vaccines with or without simultaneous pneumococcal vaccine in The Netherlands. Vaccine 26(46):5883-5887.
153. Enriquez, R., T. Hartert, and V. Persky. 2007. Trends in asthma prevalence and recommended number of childhood immunizations are not parallel. Pediatrics 119(1):222-223.
154. Fombonne, E., R. Zakarian, A. Bennett, L. Meng, and D. McLean-Heywood. 2006. Pervasive developmental disorders in Montreal, Quebec, Canada: Prevalence and links with immunizations. Pediatrics 118(1):e139-e150.
155. Geier, D.A., and M.R. Geier. 2003. An assessment of the impact of thimerosal on childhood neurodevelopmental disorders. Pediatric Rehabilitation 6(2):97-102.
156. Geier, D.A., and M.R. Geier. 2004a. Neurodevelopmental disorders following thimerosalcontaining childhood immunizations: A follow-up analysis. International Journal of Toxicology 23(6):369-376.
157. Geier, D.A., and M.R. Geier. 2004b. A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism. Medical Science Monitor 10(3):PI33-PI39.
158. Geier, D.A., and M.R. Geier. 2006. An assessment of downward trends in neurodevelopmental disorders in the United States following removal of thimerosal from childhood vaccines. Medical Science Monitor 12(6):CR231-CR239.
159. Gruber, C., S. Illi, S. Lau, R. Nickel, J. Forster, W. Kamin, C.P. Bauer, V. Wahn, U. Wahn, and the MAS-90 Study Group. 2003. Transient suppression of atopy in early childhood is associated with high vaccination coverage. Pediatrics 111(3):e282-e288.
160. Heron, J., J. Golding, and the ALSPAC Study Team. 2004. Thimerosal exposure in infants and developmental disorders: A prospective cohort study in the United Kingdom does not support a causal association. Pediatrics 114(3):577-583.
161. Hviid, A., M. Stellfeld, J. Wohlfahrt, and M. Melbye. 2003. Association between thimerosalcontaining vaccine and autism. Journal of the American Medical Association 290(13): 1763-1766.
162. Hviid, A., M. Stellfeld, J. Wohlfahrt, and M. Melbye. 2004. Childhood vaccination and type 1 diabetes. New England Journal of Medicine 350(14):1398-1404.
163. IOM (Institute of Medicine). 1994. Adverse events associated with childhood vaccines: Evidence bearing on causality. Washington, DC: National Academy Press.
164. IOM. 2002. Immunization safety review: Multiple immunizations and immune dysfunction. Washington, DC: National Academy Press.
165. IOM. 2011. Finding what works in health care: Standards of systematic reviews. Washington, DC: The National Academies Press.
166. IOM. 2012. Adverse effects of vaccines: Evidence and causality. Washington, DC: The National Academies Press.
167. Klein, N.P., B. Fireman, W.K. Yih, E. Lewis, M. Kulldorff, P. Ray, R. Baxter, S. Hambidge, J. Nordin, A. Naleway, E.A. Belongia, T. Lieu, J. Baggs, E. Weintraub, and Vaccine Safety Datalink. 2010. Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures. Pediatrics 126(1):e1-e8.
168. Madsen, K.M., M.B. Lauritsen, C.B. Pedersen, P. Thorsen, A.M. Plesner, P.H. Andersen, and P.B. Mortensen. 2003. Thimerosal and the occurrence of autism: Negative ecological evidence from Danish population-based data. Pediatrics 112(3 Pt 1):604-606.
169. Maher, J.E., J.P. Mullooly, L. Drew, and F. DeStefano. 2004. Infant vaccinations and childhood asthma among full-term infants. Pharmacoepidemiology and Drug Safety 13(1):1-9.
170. Maitra, A., A. Sherriff, M. Griffiths, J. Henderson, and the Avon Longitudinal Study of Parents and Children Study Team. 2004. Pertussis vaccination in infancy and asthma or allergy in later childhood: Birth cohort study. BMJ 328(7445):925-926.
171. Marques, R.C., J.G. Dorea, A.G. Manzatto, W.R. Bastos, J.V.E. Bernardi, and O. Malm. 2007. Time of perinatal immunization, thimerosal exposure and neurodevelopment at 6 months in breastfed infants. Acta Paediatrica 96(6):864-868.
172. Martignon, G., M.-P. Oryszczyn, and I. Annesi-Maesano. 2005. Does childhood immunization against infectious diseases protect from the development of atopic disease? Pediatric Allergy and Immunology 16(3):193-200.
173. Matheson, M.C., E. Haydn Walters, J.A. Burgess, M.A. Jenkins, G.G. Giles, J.L. Hopper, M.J. Abramson, and S.C. Dharmage. 2010. Childhood immunization and atopic disease into middle-age-A prospective cohort study. Pediatric Allergy and Immunology 21(2 Pt 1):301-306.
174. McDonald, K.L., S.I. Huq, L.M. Lix, A.B. Becker, and A.L. Kozyrskyj. 2008. Delay in diphtheria, pertussis, tetanus vaccination is associated with a reduced risk of childhood asthma. Journal of Allergy and Clinical Immunology 121(3):626-631.
175. McKeever, T.M., S.A. Lewis, C. Smith, and R. Hubbard. 2004. Vaccination and allergic disease: A birth cohort study. American Journal of Public Health 94(6):985-989.
176. Mullooly, J.P., R. Schuler, M. Barrett, and J.E. Maher. 2007. Vaccines, antibiotics, and atopy. Pharmacoepidemiology and Drug Safety 16(3):275-288.
177. Nilsson, L., N.I.M. Kjellman, and B. Bjorksten. 2003. Allergic disease at the age of 7 years after pertussis vaccination in infancy: Results from the follow-up of a randomized controlled trial of 3 vaccines. Archives of Pediatrics and Adolescent Medicine 157(12):1184-1189.
178. O'Leary, S.T., J.M. Glanz, D.L. McClure, A. Akhtar, M.F. Daley, C. Nakasato, R. Baxter, R.L. Davis, H.S. Izurieta, T.A. Lieu, and R. Ball. 2012. The risk of immune thrombocytopenic purpura after vaccination in children and adolescents. Pediatrics 129(2):248-255.
179. Smith, M.J., and C.R. Woods. 2010. The risk of immune thrombocytopenic purpura after vaccination in children and adolescents. Pediatrics 129(2):248-255.
180. Spycher, B.D., M. Silverman, M. Egger, M. Zwahlen, and C.E. Kuehni. 2009. Routine vaccination against pertussis and the risk of childhood asthma: A population-based cohort study. Pediatrics 123(3):944-950. [Erratum, Pediatrics 123(5):1437, 2009.]
181. Sun, Y., J. Christensen, A. Hviid, J. Li, P. Vedsted, J. Olsen, and M. Vestergaard. 2012. Risk of febrile seizures and epilepsy after vaccination with diphtheria, tetanus, acellular pertussis, inactivated poliovirus, and Haemophilus influenzae type B. Journal of the American Medical Association 307(8):823-831.
182. Thompson, W.W., C. Price, B. Goodson, D.K. Shay, P. Benson, V.L. Hinrichsen, E. Lewis, E. Eriksen, P. Ray, S.M. Marcy, J. Dunn, L.A. Jackson, T.A. Lieu, S. Black, G. Stewart, E.S. Weintraub, R.L. Davis, F. DeStefano, and the Vaccine Safety Datalink Team. 2007. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. New England Journal of Medicine 357(13):1281-1292.
183. Thomson, J.A., C. Widjaja, A.A.P. Darmaputra, A. Lowe, M.C. Matheson, C.M. Bennett, K. Allen, M.J. Abramson, C. Hosking, D. Hill, and S.C. Dharmage. 2010. Early childhood infections and immunisation and the development of allergic disease in particular asthma in a high-risk cohort: A prospective study of allergy-prone children from birth to six years. Pediatric Allergy and Immunology 21(7):1076-1085.
184. Tozzi, A.E., P. Bisiacchi, V. Tarantino, B. De Mei, L. D'Elia, F. Chiarotti, and S. Salmaso. 2009. Neuropsychological performance 10 years after immunization in infancy with thimerosalcontaining vaccines. Pediatrics 123(2):475-482.
185. Tse, A., H.F. Tseng, S.K. Greene, C. Vellozzi, G.M. Lee, and the VSD Rapid Cycle Analysis Influenza Working Group. 2012. Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011. Vaccine 30 (11):2024-2031.
186. Verstraeten, T., R.L. Davis, F. DeStefano, T.A. Lieu, P.H. Rhodes, S.B. Black, H. Shinefield, R.T. Chen, and the Vaccine Safety Datalink Team. 2003. Safety of thimerosal-containing vaccines: A two-phased study of computerized health maintenance organization databases. Pediatrics 112(5):1039-1048. [Erratum, Pediatrics, 113(1):184, 2004.]
187. Verstraeten, T., D. Descamps, M.-P. David, T. Zahaf, K. Hardt, P. Izurieta, G. Dubin, and T. Breuer. 2008. Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines. Vaccine 26(51):6630-6638.
188. Yong, M., W.M. Schoonen, L. Li, G. Kanas, J. Coalson, F. Mowat, J. Fryzek, and J.A. Kaye. 2010. Epidemiology of paediatric immune thrombocytopenia in the general practice research database. British Journal of Haematology 149(6):855-864.
189. Young, H.A., D.A. Geier, and M.R. Geier. 2008. Thimerosal exposure in infants and neurodevelopmental disorders: An assessment of computerized medical records in the Vaccine Safety Datalink. Journal of the Neurological Sciences 271(1-2):110-118.
190. Anderson, R.M., and R.M. May. 1992. Infectious Diseases of Humans: Dynamics and Control, New York: Oxford University Press.
191. Baggs, J., J. Gee, E. Lewis, G. Fowler, P. Benson, T. Lieu, A. Naleway, N.P. Klein, R. Baxter, E. Belongia, J. Glanz, S.J. Hambidge, S.J. Jacobsen, L. Jackson, J. Nordin, and E. Weintraub. 2011. The Vaccine Safety Datalink: A model for monitoring immunization safety. Pediatrics 127(Suppl 1):S45-S53.
192. Blower, S.M. 2000. A tale of two futures: HIV and antiretroviral therapy in San Francisco. Science 287(5453):650-654.
193. Carlsson, R.M., and B. Trollfors. 2009. Control of pertussis-lessons learnt from a 10-year surveillance programme in Sweden. Vaccine 27(42):5709-5718.
194. Chen, R.T., J.W. Glasser, P.H. Rhodes, R.L. Davis, W.E. Barlow, R.S. Thompson, J.P. Mullooly, S.B. Black, H.R. Shinefield, and C.M. Vadheim. 1997. Vaccine Safety Datalink project: A new tool for improving vaccine safety monitoring in the United States. Pediatrics 99(6):765-773.
195. Cobey, S., and M. Lipsitch. 2012. Niche and neutral effects of acquired immunity permit coexistence of pneumococcal serotypes. Science 335(6074):1376-1380.
196. Del Valle, S.Y., J. Hyman, H.W. Hethcote, and S.G. Eubank. 2007. Mixing patterns between age groups in social networks. Social Networks 29(4):539-554.
197. DeStefano, F. 2001. The Vaccine Safety Datalink project. Pharmacoepidemiology and Drug Safety 10(5):403-406.
198. Edmunds, W.J., M. Brisson, A. Melegaro, and N.J. Gay. 2002. The potential cost-effectiveness of acellular pertussis booster vaccination in England and Wales. Vaccine 20(9):1316-1330.
199. Ferguson, N.M., R.M. Anderson, and G.P. Garnett. 1996. Mass vaccination to control chickenpox: The influence of zoster. Proceedings of the National Academy of Sciences of the United States of America 93(14):7231-7235.
200. Friedman, L.M., C.D. Furberg, and D.L. DeMets. 2010. Fundamentals of clinical trials. New York, NY: Springer.
201. Gangarosa, E.J., A. Galazka, C. Wolfe, L. Phillips, R. Gangarosa, E. Miller, and R. Chen. 1998. Impact of anti-vaccine movements on pertussis control: The untold story. Lancet 351(9099):356-361.
202. Gibson, M.A., and J. Bruck. 2000. Efficient exact stochastic simulation of chemical systems with many species and many channels. Journal of Physical Chemistry A 104(9): 1876-1889.
203. Gillespie, D.T. 1977. Exact stochastic simulation of coupled chemical reactions. Journal of Chemical Physics 81(25):2340-2361.
204. Glanz, J.M., S.R. Newcomer, K.J. Narwaney, S.J. Hambidge, M.F. Daley, N.M. Wagner, D.L. McClure, S. Xu, A. Rowhani-Rahbar, G.M. Lee, J.C. Nelson, J.G. Donahue, A.L. Naleway, J.D. Nordin, M.M. Lugg, and E.S. Weintraub. 2013. A population-based cohort study of undervaccination in 8 managed care organizations across the United States. JAMA Pediatrics: 1-8.
205. Goldwyn, E.E., and P. Rohani. 2012. Bias in pertussis incidence data and its implications for public health epidemiology. Journal of Public Health Management and Practice. Epub ahead of press.
206. Gust, D.A., S. Campbell, A. Kennedy, I. Shui, L. Barker, and B. Schwartz. 2006. Parental concerns and medical-seeking behavior after immunization. American Journal of Preventive Medicine 31(1):32-35.
207. Gust, D.A., D. Weber, E. Weintraub, A. Kennedy, F. Soud, and A. Burns. 2008. Physicians who do and do not recommend children get all vaccinations. Journal of Health Communication 13(6):573-582.
208. Heiniger, U., K. Klich, K. Stehr, and J.D. Cherry. 1997. Clinical findings in Bordatella pertussis infections: Results of a prospective multicenter surveillance study. Pediatrics 100(6):e10.
209. Hethcote, H. 1998. Oscillations in an endemic model for pertussis. Canadian Applied Mathematics Quarterly 6:61-88.
210. Hogan, M.B., K.E. Harris, and R. Patterson. 1994. A naturally occurring model of immunoglobulin E antibody-mediated hypersensitivity in laboratory animals. Journal of Laboratory and Clinical Medicine 123(6):899-905.
211. IOM (Institute of Medicine). 2002. Immunization safety review: Multiple immunizations and immune dysfunction. Washington, DC: National Academy Press.
212. IOM. 2012. Adverse effects of vaccines. Washington, DC: The National Academies Press.
213. Ionides, E., C. Bretó, and A. King. 2006. Inference for nonlinear dynamical systems. Proceedings of the National Academy of Sciences of the United States of America 103(49): 18438-18443.
214. Jansen, V.A.A., N. Stollenwerk, H.J. Jensen, M. Ramsay, W. Edmunds, and C. Rhodes. 2003. Measles outbreaks in a population with declining vaccine uptake. Science 301(5634):804.
215. Jit, M., Y.H. Choi, and W.J. Edmunds. 2008. Economic evaluation of human papillomavirus vaccination in the United Kingdom. British Medical Journal 337:a769.
216. Kanesa-thasan, N., A. Shaw, J.J. Stoddard, and T.M. Vernon. 2011. Ensuring the optimal safety of licensed vaccines: A perspective of the vaccine research, development, and manufacturing companies. Pediatrics 127(Suppl 1):S16-S22.
217. Keeling, M.J., and P. Rohani. 2008. Modeling Infectious Diseases in Humans and Animals. Princeton, NJ: Princeton University Press.
218. Levi, B.H. 2007. Addressing parents' concerns about childhood immunizations: A tutorial for primary care providers. Pediatrics 120(1):18-26.
219. Medlock, J., and A.P. Galvani. 2009. Optimizing influenza vaccine distribution. Science 325(5948):1705-1708.
220. Metcalf, C., C. Munayco, G. Chowell, B. Grenfell, and O. Bjørnstad. 2011. Rubella metapopulation dynamics and importance of spatial coupling to the risk of congenital rubella syndrome in Peru. Journal of the Royal Society Interface 8(56):369-376.
221. Mossong, J., N. Hens, M. Jit, P. Beutels, K. Auranen, R. Mikolajczyk, M. Massari, S. Salmaso, G.S. Tomba, and J. Wallinga. 2008. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Medicine 5(3):e74.
222. National Children's Study. 2012. About the study. Bethesda, MD: National Children's Study. http://www.nationalchildrensstudy.gov/about/Pages/default.aspx (accessed October 5, 2012).
223. Park, A.W., J.M. Daly, N.S. Lewis, D.J. Smith, J.L.N. Wood, and B.T. Grenfell. 2009. Quantifying the impact of immune escape on transmission dynamics of influenza. Science 326(5953):726-728.
224. Rohani, P., R. Breban, D.E. Stallknecht, and J.M. Drake. 2009. Environmental transmission of low pathogenicity avian influenza viruses and its implications for pathogen invasion. Proceedings of the National Academy of Sciences of the United States of America 106(25):10365-10369.
225. Rohani, P., X. Zhong, and A.A. King. 2010. Contact network structure explains the changing epidemiology of pertussis. Science 330(6006):982-985.
226. Romanus, V., R. Jonsell, and S.O. Bergquist. 1987. Pertussis in Sweden after the cessation of general immunization in 1979. Pediatric Infectious Disease Journal 6(4):364-371.
227. Schenzle, D. 1984. An age-structured model of pre-and post-vaccination measles transmission. Mathematical Medicine and Biology 1(2):169-191.
228. Sears, R.W. 2011. The vaccine book: Making the right decision for your child. New York, NY: Little, Brown and Company.
229. Smith, P.J., S.Y. Chu, and L.E. Barker. 2004. Children who have received no vaccines: Who are they and where do they live? Pediatrics 114(1):187-195.
230. Trotter, C.L., and W.J. Edmunds. 2006. Reassessing the cost-effectiveness of meningococcal serogroup C conjugate (MCC) vaccines using a transmission dynamic model. Medical Decision Making 26(1):38-47.
231. Wenger, O.K., M.D. McManus, J.R. Bower, and D.L. Langkamp. 2011. Underimmunization in Ohio; Amish: Parental fears are a greater obstacle than access to care. Pediatrics 128(1):79-85.
232. CDC (Centers for Disease Control and Prevention). 2011. Immunization Safety Office scientific agenda. Atlanta, GA: Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention.
233. HHS (Department of Health and Human Services). 2010. 2010 National Vaccine Plan. Washington, DC: Department of Health and Human Services.
234. IOM (Institute of Medicine). 2012. Adverse effects of vaccines: Evidence and causality. Washington, DC: The National Academies Press.
235. NVAC (National Vaccine Advisory Committee). 2009. Recommendations on the Centers for Disease Control and Prevention Immunization Safety Office draft 5-year scientific agenda. Washington, DC: National Vaccine Advisory Committee.
236. Aaby, P., H. Jensen, J. Gomes, M. Fernandes, and I. M. Lisse. 2004. The introduction of diphtheria-tetanus-pertussis vaccine and child mortality in rural guinea-bissau: An observational study. International Journal of Epidemiology 33(2):374-380.
237. Almenoff, J. S., W. DuMouchel, L. A. Kindman, X. Yang, and D. Fram. 2003. Disproportionality analysis using empirical Bayes data mining: A tool for the evaluation of drug interactions in the post-marketing setting. Pharmacoepidemiol Drug Safety 12(6):517-521.
238. Baggs, J., J. Gee, E. Lewis, G. Fowler, P. Benson, T. Lieu, A. Naleway, N. P. Klein, R. Baxter, E. Belongia, J. Glanz, S. J. Hambidge, S. J. Jacobsen, L. Jackson, J. Nordin, and E. Weintraub. 2011. The Vaccine Safety Datalink: A model for monitoring immunization safety. Pediatrics 127(Suppl 1):S45-S53.
239. Bate, A., M. Lindquist, I. R. Edwards, S. Olsson, R. Orre, A. Lansner, and R. M. De Freitas. 1998. A Bayesian neural network method for adverse drug reaction signal generation. The European Journal of Clinical Pharmacology 54(4):315-321.
240. CDC (Centers for Disease Control and Prevention). 2012. Recommended immunization schedule for persons aged 0 through 6 years-United States, 2012. Atlanta, GA: Centers for Disease Control and Prevention.
241. Chen, R. T., J. W. Glasser, P. H. Rhodes, R. L. Davis, W. E. Barlow, R. S. Thompson, J. P. Mullooly, S. B. Black, H. R. Shinefield, C. M. Vadheim, S. M. Marcy, J. I. Ward, R. P. Wise, S. G. Wassilak, and S. C. Hadler. 1997. Vaccine Safety Datalink project: A new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink team. Pediatrics 99(6):765-773.
242. DeStefano, F., and the Vaccine Safety Datalink Research Group. 2001. The Vaccine Safety Datalink project. Pharmacoepidemiol Drug Safety 10(5):403-406.
243. DeStefano, F., E. Weintraub, and C. Price. 2012. Immunogenic stimulation from vaccines and risk of autism. Paper presented at Vaccine Safety Datalink Annual Meeting, Denver, CO.
244. DuMouchel, W. 1999. Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system. Journal of the American Statistical Association 53(3):177-190.
245. Eng, P. M., T. C. Mast, J. Loughlin, C. R. Clifford, J. Wong, and J. D. Seeger. 2012. Incidence of intussusception among infants in a large commercially insured population in the United States. Pediatric Infectious Disease Journal 31(3):287-291.
246. Evans, S. J., P. C. Waller, and S. Davis. 2001. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Safety 10(6):483-486.
247. Fireman, B., J. Lee, N. Lewis, O. Bembom, M. van der Laan, and R. Baxter. 2009. Influenza vaccination and mortality: Differentiating vaccine effects from bias. American Journal of Epidemiology 170(5):650-656.
248. Gargiullo, P. M., T. V. Murphy, and R. L. Davis. 2006. Is there a safe age for vaccinating infants with tetravalent rhesus-human reassortant rotavirus vaccine? The Journal of Infectious Diseases 194(12):1793-1794.
249. Glanz, J. 2012. Alternative immunization schedules and the risk of pertussis. Paper presented at Vaccine Safety Datalink Annual Meeting, Denver, CO.
250. Hambidge, S. J. 2012. Seizures in children with recommended versus delayed infant immunization schedules. Paper presented at Vaccine Safety Datalink Annual Meeting, Denver, CO.
251. Hambidge, S. J., J. M. Glanz, E. K. France, D. McClure, S. Xu, K. Yamasaki, L. Jackson, J. P. Mullooly, K. M. Zangwill, S. M. Marcy, S. B. Black, E. M. Lewis, H. R. Shinefield, E. Belongia, J. Nordin, R. T. Chen, D. K. Shay, R. L. Davis, F. DeStefano, and the Vaccine Safety Datalink Team. 2006. Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old. Journal of the American Medical Association 296(16):1990-1997.
252. Hsiao, C. J., E. Hing, T. C. Socey, and B. Cai. 2011. Electronic health record systems and intent to apply for meaningful use incentives among office-based physician practices: United States, 2001-2011. NCHS Data Brief (79):1-8.
253. Iqbal, S., and F. DeStefano. 2012. Immunological-stimulating content of vaccines and neurophysiological outcomes in children. Paper presented at Vaccine Safety Datalink Annual Meeting, Denver, CO.
254. Klein, N. P., B. Fireman, W. K. Yih, E. Lewis, M. Kulldorff, P. Ray, R. Baxter, S. Hambidge, J. Nordin, A. Naleway, E. A. Belongia, T. Lieu, J. Baggs, E. Weintraub, and Vaccine Safety Datalink. 2010. Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures. Pediatrics 126(1):e1-e8.
255. Kramarz, P., E. K. France, F. DeStefano, S. B. Black, H. Shinefield, J. I. Ward, E. J. Chang, R. T. Chen, D. Shatin, J. Hill, T. Lieu, and J. M. Ogren. 2001. Population-based study of rotavirus vaccination and intussusception. Pediatric Infectious Disease Journal 20(4):410-416.
256. Kulldorff, M., R. L. Davis, M. Kolczak, E. Lewis, T. Lieu, and R. Platt. 2011. A maximized sequential probability ratio test for drug and vaccine safety surveillance. Sequential Analysis 30(1):58-78.
257. LaRussa, P. S., K. M. Edwards, C. L. Dekker, N. P. Klein, N. A. Halsey, C. Marchant, R. Baxter, R. J. Engler, J. Kissner, and B. A. Slade. 2011. Understanding the role of human variation in vaccine adverse events: The Clinical Immunization Safety Assessment Network. Pediatrics 127(Suppl 1):S65-S73.
258. Leonardi, M., K. Bromberg, R. Baxter, J. L. Gardner, S. Klopfer, O. Nicholson, M. Brockley, J. Trammel, V. Leamy, W. Williams, B. Kuter, and F. Schodel. 2011. Immunogenicity and safety of MMRV and PCV-7 administered concomitantly in healthy children. Pediatrics 128(6):e1387-e1394.
259. Lieu, T. A., M. Kulldorff, R. L. Davis, E. M. Lewis, E. Weintraub, K. Yih, R. Yin, J. S. Brown, R. Platt, and for the Vaccine Safety Datalink Rapid Cycle Analysis Team. 2007. Realtime vaccine safety surveillance for the early detection of adverse events. Medical Care 45(10 Suppl 2):S89-S95.
260. Murphy, T. V., P. M. Gargiullo, M. S. Massoudi, D. B. Nelson, A. O. Jumaan, C. A. Okoro, L. R. Zanardi, S. Setia, E. Fair, C. W. LeBaron, M. Wharton, J. R. Livengood, and the Rotavirus Intussusception Investigation Team. 2001. Intussusception among infants given an oral rotavirus vaccine. New England Journal of Medicine 344(8):564-572.
261. Nguyen, M., R. Ball, K. Midthun, and T. A. Lieu. 2012. The Food and Drug Administration's post-licensure rapid immunization safety monitoring program: Strengthening the federal vaccine safety enterprise. Pharmacoepidemiol Drug Safety 21(Suppl 1):S291-S297.
262. Norén, G. N., R. Sundberg, A. Bate, and I. R. Edwards. 2008. A statistical methodology for drug-drug interaction surveillance. Statistics in Medicine 27(16):3057-3070.
263. Pittman, P. R. 2002. Aluminum-containing vaccine associated adverse events: Role of route of administration and gender. Vaccine 20(Suppl 3):S48-S50.
264. Price, C. S., W. W. Thompson, B. Goodson, E. S. Weintraub, L. A. Croen, V. L. Hinrichsen, M. Marcy, A. Robertson, E. Eriksen, E. Lewis, P. Bernal, D. Shay, R. L. Davis, and F. DeStefano. 2010. Prenatal and infant exposure to thimerosal from vaccines and immunoglobulins and risk of autism. Pediatrics 126(4):656-664.
265. Rothman, A. L. 2011. Immunity to dengue virus: A tale of original antigenic sin and tropical cytokine storms. Nature Reviews Immunology 11(8):532-543.
266. Rothman, K. J., Y. Young-Xu, and F. Arellano. 2006. Age dependence of the relation between reassortant rotavirus vaccine (RotaShield) and intussusception. The Journal of Infectious Diseases 193(6):898.
267. Rowhani-Rahbar, A., N. Lewis, B. Fireman, R. Baxter, N. Klein, and other VSD colleagues. 2012. Effect of age on the risk of seizure following immunization with measles-containing vaccines: VSD study 233-preliminary results. Paper presented at Vaccine Safety Datalink Annual Meeting, Denver, CO.
268. Sears, R. 2007. The vaccine book: Making the right decision for your child, 1st ed. New York: Little, Brown.
269. Thakrar, B. T., S. B. Grundschober, and L. Doessegger. 2007. Detecting signals of drug-drug interactions in a spontaneous reports database. The British Journal of Clinical Pharmacology 64(4):489-495.
270. Tse, A., H. F. Tseng, S. K. Greene, C. Vellozzi, G. M. Lee, and the VSD Rapid Cycle Analysis Influenza Working Group. 2012. Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink project, 2010-2011. Vaccine 30(11):2024-2031.
271. Veirum, J. E., M. Sodemann, S. Biai, M. Jakobsen, M. L. Garly, K. Hedegaard, H. Jensen, and P. Aaby. 2005. Routine vaccinations associated with divergent effects on female and male mortality at the paediatric ward in Bissau, Guinea-Bissau. Vaccine 23(9):1197-1204.
272. Yih, W. K., M. Kulldorff, B. H. Fireman, I. M. Shui, E. M. Lewis, N. P. Klein, J. Baggs, E. S. Weintraub, E. A. Belongia, A. Naleway, J. Gee, R. Platt, and T. A. Lieu. 2011. Active surveillance for adverse events: The experience of the Vaccine Safety Datalink project. Pediatrics 127(Suppl 1):S54-S64.